Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05119179
What this trial is testing

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

Who this might be right for
PreDiabetes
The University of Texas Health Science Center, Houston 300
Not applicableLooking for participantsNCT07006142
What this trial is testing

Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

Who this might be right for
Upper EndoscopyGLP1-R-related Disease
Mayo Clinic 150
Testing effectiveness (Phase 2)UnknownNCT02127996
What this trial is testing

GLP-1 Loading During Elective Percutaneous Coronary Intervention

Who this might be right for
Angina PectorisMyocardial InfarctionReperfusion Injury+1 more
Papworth Hospital NHS Foundation Trust 193
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Not applicableLooking for participantsNCT07103083
What this trial is testing

Postprandial Response to Fruit Juice

Who this might be right for
Blood GlucoseBlood Insulin
Ocean Spray Cranberries, Inc. 18
Not applicableStudy completedNCT07012317
What this trial is testing

A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications

Who this might be right for
Gastrointestinal SymptomsWeight LossGLP-1
Midwest Center for Metabolic and Cardiovascular Research 50
Not applicableLooking for participantsNCT07082062
What this trial is testing

Effects of GLP-1 Formula on GLP-1 and Glucose Regulation

Who this might be right for
Overweight
Shih Chien Huang 100
Not applicableEnded earlyNCT03889496
What this trial is testing

Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin

Who this might be right for
Diabetes Mellitus
Radboud University Medical Center 12
Not applicableUnknownNCT03182296
What this trial is testing

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

Who this might be right for
Gestational Diabetes
Radboud University Medical Center 24
Post-approval studies (Phase 4)Study completedNCT02686177
What this trial is testing

Effect of GLP-1 on Angiogenesis

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07431086
What this trial is testing

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

Who this might be right for
Overweight or Obesity
Regeneron Pharmaceuticals 120
Very early researchActive Not RecruitingNCT06807970
What this trial is testing

Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist

Who this might be right for
Osteoarthritis (OA) of the Knee
The University of Hong Kong 54
Not applicableStudy completedNCT01571622
What this trial is testing

Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Tel Aviv University 19
Not applicableStudy completedNCT04295005
What this trial is testing

A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 24,500
Early research (Phase 1)UnknownNCT02971722
What this trial is testing

JY09 in Chinese Healthy Subjects

Who this might be right for
Healthy
Beijing Dongfang Biotech Co., Ltd. 26
Not applicableLooking for participantsNCT07653412
What this trial is testing

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Who this might be right for
Obesity (Disorder)Anti-obesity AgentsPrecision Medicine
National and Kapodistrian University of Athens 220
Large-scale testing (Phase 3)Not Yet RecruitingNCT07668336
What this trial is testing

Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 170
Post-approval studies (Phase 4)Study completedNCT01744236
What this trial is testing

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 70
Early research (Phase 1)Study completedNCT01572753
What this trial is testing

Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 161
Post-approval studies (Phase 4)Study completedNCT04196231
What this trial is testing

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

Who this might be right for
Type 2 Diabetes
University of Campania Luigi Vanvitelli 258
Next Page